674 related articles for article (PubMed ID: 19187609)
1. Prevalence of antinuclear and anti-liver-kidney-microsome type-1 antibodies in patients with chronic hepatitis C in China.
Bai L; Feng ZR; Lu HY; Li WG; Yu M; Xu XY
Chin Med J (Engl); 2009 Jan; 122(1):5-9. PubMed ID: 19187609
[TBL] [Abstract][Full Text] [Related]
2. [Detection and the production mechanism of antinuclear antibodies (ANA) and anti-liver/kidney microsomal tpe 1 antibodies (anti-LKM1) in patients with chronic hepatitis C].
Bai L; Lu HY; Feng ZR; Yu M; Li WG; Gong WB; Zhao NE; Xu XY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):278-81. PubMed ID: 20108773
[TBL] [Abstract][Full Text] [Related]
3. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
5. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
[TBL] [Abstract][Full Text] [Related]
6. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies in chronic hepatitis C virus infection and their association with disease profile.
Williams MJ; Lawson A; Neal KR; Ryder SD; Irving WL;
J Viral Hepat; 2009 May; 16(5):325-31. PubMed ID: 19302340
[TBL] [Abstract][Full Text] [Related]
8. [Anti LKM-1 antibodies and cryoglobulinemia in autoimmune chronic hepatitis and virus C hepatitis].
Jirón MI; Ardiles A; Parra MA; Orellana J
Rev Med Chil; 2000 Mar; 128(3):273-8. PubMed ID: 10962868
[TBL] [Abstract][Full Text] [Related]
9. Anti-C-reactive protein antibodies in chronic hepatitis C infection: correlation with severity and autoimmunity.
Kessel A; Elias G; Pavlotzky E; Zuckerman E; Rosner I; Toubi E
Hum Immunol; 2007 Oct; 68(10):844-8. PubMed ID: 17961773
[TBL] [Abstract][Full Text] [Related]
10. Serological markers of autoimmunity in patients infected with hepatitis C virus: impact of HIV co-infection.
Adeyemi OM; Attar B; Jensen D; Ghaoui R; Cotler SJ
HIV Med; 2005 Nov; 6(6):371-4. PubMed ID: 16268816
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to asialoglycoprotein receptor in chronic hepatitis C patients.
Husa P; Chalupa P; Stroblová H; Husová L; Slesinger P; Zajíc J
Acta Virol; 2001 Feb; 45(1):7-11. PubMed ID: 11394582
[TBL] [Abstract][Full Text] [Related]
12. Antinuclear antibody positivity in patients with chronic hepatitis C: clinically relevant or an epiphenomenon?
Narciso-Schiavon JL; Freire FC; Suarez MM; Ferrari MV; Scanhola GQ; Schiavon Lde L; de Carvalho Filho RJ; Ferraz ML; Silva AE
Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):440-6. PubMed ID: 19382301
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
[TBL] [Abstract][Full Text] [Related]
14. Anti-ENA antibody profile in hepatitis C patients undergoing hemodialysis.
Batchoun RG; Al-Najdawi MA; Al-Taamary S
Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):682-8. PubMed ID: 21743211
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of autoantibodies in patients with endemic pemphigus foliaceus (fogo selvagem).
Nisihara RM; de Bem RS; Hausberger R; Roxo VS; Pavoni DP; Petzl-Erler ML; de Messias-Reason IJ
Arch Dermatol Res; 2003 Aug; 295(4):133-7. PubMed ID: 12844225
[TBL] [Abstract][Full Text] [Related]
16. Antinuclear antibody positivity in patients with chronic hepatitis C: clinically relevant or an epiphenomenon?
Narciso-Schiavon JL; Freire FC; Suarez MM; Ferrari MV; Scanhola GQ; Schiavon Lde L; Carvalho Filho RJ; Ferraz ML; Silva AE
Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):350-6. PubMed ID: 20611005
[TBL] [Abstract][Full Text] [Related]
17. Differences in anti-LKM-1 autoantibody immunoreactivity to CYP2D6 antigenic sites between hepatitis C virus-negative and -positive patients.
Kitazawa E; Igarashi T; Kawaguchi N; Matsushima H; Kawashima Y; Hankins RW; Miyakawa H
J Autoimmun; 2001 Nov; 17(3):243-9. PubMed ID: 11712862
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune thyroid disease and autoimmune rheumatic disorders: a two-sided analysis.
Lazúrová I; Benhatchi K; Rovenský J; Kozáková D; Wagnerová H; Tajtáková M; Shoenfeld Y; Macejova Z
Ann N Y Acad Sci; 2009 Sep; 1173():211-6. PubMed ID: 19758153
[TBL] [Abstract][Full Text] [Related]
19. [A prospective study on the prevalence and clinical significance of autoantibodies in patients with suspected nonalcoholic fatty liver disease].
Cho DH; Choi MS; Kim DH; Kim DY; Shim SG; Lee JH; Koh KC; Paik SW; Yoo BC; Rhee JC
Korean J Hepatol; 2005 Sep; 11(3):261-7. PubMed ID: 16177552
[TBL] [Abstract][Full Text] [Related]
20. [Autoantibodies in chronic hepatitis C. Markers of autoimmunity or non-specific events?].
Vella FS; Orlando P; Attanasi F; Simone B; Mundo A; Lopalco P; Schiraldi O; Antonaci S
Recenti Prog Med; 2001 Feb; 92(2):107-12. PubMed ID: 11294098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
